SIC
SJS Investment Consulting’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.65K | Hold |
34
| – | – | ﹤0.01% | 633 |
|
|
2025
Q1 | $1.16K | Hold |
34
| – | – | ﹤0.01% | 953 |
|
|
2024
Q4 | $1.34K | Sell |
34
-30
| -47% | -$1.18K | ﹤0.01% | 898 |
|
|
2024
Q3 | $3.01K | Sell |
64
-370
| -85% | -$17.4K | ﹤0.01% | 624 |
|
|
2024
Q2 | $23.4K | Buy |
434
+20
| +5% | +$1.08K | ﹤0.01% | 251 |
|
|
2024
Q1 | $28.2K | Hold |
414
| – | – | 0.01% | 241 |
|
|
2023
Q4 | $25.9K | Buy |
414
+10
| +2% | +$626 | 0.01% | 218 |
|
|
2023
Q3 | $18.3K | Buy |
404
+370
| +1,088% | +$16.8K | ﹤0.01% | 240 |
|
|
2023
Q2 | $1.91K | Hold |
34
| – | – | ﹤0.01% | 622 |
|
|
2023
Q1 | $1.54K | Hold |
34
| – | – | ﹤0.01% | 690 |
|
|
2022
Q4 | $1.38K | Hold |
34
| – | – | ﹤0.01% | 800 |
|
|
2022
Q3 | $2K | Buy |
+34
| New | +$2K | ﹤0.01% | 444 |
|
|
2022
Q1 | $2K | Buy |
35
+1
| +3% | +$57 | ﹤0.01% | 507 |
|
|
2021
Q4 | $3K | Buy |
+34
| New | +$3K | ﹤0.01% | 449 |
|